STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
ARDX ARDELYX INCORPORATED StockScouter® Report
4
StockScouter® Score
ARDELYX INCORPORATED, a small cap growth company in the healthcare sector, is expected to slightly underperform the market over the next six months with average risk
10 is the best possible rating. Learn more.
Summary
Positives
- The most recent quarterly earnings report was significantly higher than analysts’ consensus forecast. Positive
- One or more analysts has significantly increased quarterly earnings estimates for ARDX. Positive
Concerns
- Two or more executives, board directors or major shareholders – including one high-level executive -- sold a large number of shares recently. Very negative
- The enterprise value-to-sales ratio is higher than the average for comparably-sized companies in the StockScouter universe. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, growth stocks will be neutral, and healthcare stocks will be in favor.
Expected Risk/Return
Core Model Grades
A
F
D
D